A 62-year-old postmenopausal woman presents with vaginal bleeding 18 months after her last menstrual period. Transvaginal ultrasound is performed. The structure marked **A** in the diagram measures 6 mm in thickness. What is the most appropriate next step in management?
A. Perform office endometrial biopsy (Pipelle) for tissue diagnosis
B. Proceed directly to total hysterectomy with bilateral salpingo-oophorectomy
C. Recommend routine follow-up ultrasound in 6 months
D. Reassure the patient and discharge with advice to return if bleeding persists
Explanation
Why office endometrial biopsy (Pipelle) is right
In a postmenopausal woman with bleeding, an endometrial stripe thickness >4 mm (as shown by structure A measuring 6 mm) mandates endometrial sampling per ACOG and SGO consensus. Office endometrial biopsy using a Pipelle catheter is the initial sampling modality of choice. This directly addresses the clinical anchor: the thickened endometrial stripe (>4 mm) in the setting of postmenopausal bleeding is endometrial cancer until proven otherwise, and tissue diagnosis is mandatory to distinguish between hyperplasia, atrophy, polyps, and carcinoma.
Why each distractor is wrong
Reassure and discharge: An endometrial thickness >4 mm in postmenopausal bleeding cannot be managed conservatively without sampling. This violates the principle that PMB is endometrial cancer until proven otherwise and ignores the ACOG threshold for intervention.
Routine follow-up ultrasound in 6 months: Imaging surveillance alone is inadequate when the endometrial thickness exceeds 4 mm in a bleeding patient. Tissue diagnosis is required to exclude malignancy; ultrasound cannot reliably differentiate benign from malignant pathology.
Proceed directly to hysterectomy: While hysterectomy is definitive treatment for atypical hyperplasia or confirmed endometrial cancer, it is not the first step. Tissue diagnosis via endometrial biopsy must precede surgical planning to confirm the diagnosis and grade of pathology.
High-YieldNEET PG
Postmenopausal bleeding with endometrial thickness >4 mm on TVUS → endometrial biopsy (Pipelle) is first-line tissue sampling; ≤4 mm has >99% negative predictive value for cancer and requires no further evaluation unless bleeding persists.
ACOG Practice Bulletin 734; SGO 2024
Practice similar questions
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.
